NIVALIS THERAPEUTICS INC's ticker is NVLS and the CUSIP is 65481J109. A total of 38 filers reported holding NIVALIS THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $3,984,000 | +76.8% | 490,000 | 0.0% | 0.00% | +100.0% |
| Q2 2016 | $2,254,000 | +10.3% | 490,000 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $2,043,000 | -46.1% | 490,000 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $3,793,000 | -35.9% | 490,000 | +7.4% | 0.00% | -33.3% |
| Q3 2015 | $5,918,000 | +11.6% | 456,300 | +30.4% | 0.00% | +50.0% |
| Q2 2015 | $5,303,000 | – | 350,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|